SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Neuland Laboratories informs about disclosure

13 Dec 2024 Evaluate
In reference to the letter dated November 23, 2022, regarding approval of the Board of Directors for transferring the Company’s property situated at Nanakramguda, Hyderabad, Telangana, admeasuring 1.75 lakh sq.ft. by way of perpetual lease to various parties, subject to receipt of requisite approvals and vide letters dated July 1, 2024 and November 12, 2024; Neuland Laboratories has informed about transfer of parts of the said property by way of perpetual leases, for a total consideration of Rs. 94.50 crores, for such transfers. The Company has transferred final part of the said Property by way of perpetual lease, for a consideration of Rs. 23.45 crores.

The above information is a part of company’s filings submitted to BSE.

Neuland Laboratories Share Price

14408.95 -539.25 (-3.61%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×